Hinge Health, Inc. (HNGE)
94.79
+6.20
(+7.00%)
USD |
NYSE |
Sep 14, 16:00
95.34
+0.55
(+0.58%)
After-Hours: 20:00
Hinge Health Enterprise Value : 7.219B for Sept. 14, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 7.219B |
| September 11, 2026 | 6.721B |
| September 10, 2026 | 6.695B |
| September 09, 2026 | 6.940B |
| September 08, 2026 | 7.050B |
| September 04, 2026 | 7.025B |
| September 03, 2026 | 6.896B |
| September 02, 2026 | 6.983B |
| September 01, 2026 | 6.836B |
| August 31, 2026 | 7.040B |
| August 28, 2026 | 6.622B |
| August 27, 2026 | 7.063B |
| August 26, 2026 | 6.875B |
| August 25, 2026 | 6.824B |
| August 24, 2026 | 6.833B |
| August 21, 2026 | 6.708B |
| August 20, 2026 | 6.483B |
| August 19, 2026 | 6.711B |
| August 18, 2026 | 6.693B |
| August 17, 2026 | 6.664B |
| August 14, 2026 | 6.713B |
| August 13, 2026 | 6.628B |
| August 12, 2026 | 6.539B |
| August 11, 2026 | 6.755B |
| August 10, 2026 | 6.960B |
| Date | Value |
|---|---|
| August 07, 2026 | 6.781B |
| August 06, 2026 | 6.039B |
| August 05, 2026 | 6.096B |
| August 04, 2026 | 5.986B |
| August 03, 2026 | 5.844B |
| July 31, 2026 | 5.608B |
| July 30, 2026 | 5.640B |
| July 29, 2026 | 5.556B |
| July 28, 2026 | 5.652B |
| July 27, 2026 | 5.640B |
| July 24, 2026 | 5.576B |
| July 23, 2026 | 5.767B |
| July 22, 2026 | 5.959B |
| July 21, 2026 | 6.381B |
| July 20, 2026 | 6.650B |
| July 17, 2026 | 6.601B |
| July 16, 2026 | 6.512B |
| July 15, 2026 | 6.494B |
| July 14, 2026 | 6.779B |
| July 13, 2026 | 6.835B |
| July 10, 2026 | 6.738B |
| July 09, 2026 | 6.828B |
| July 08, 2026 | 6.714B |
| July 07, 2026 | 6.778B |
| July 06, 2026 | 6.716B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services, Inc. | 24.89B |
| Vivos Therapeutics, Inc. | 14.23M |
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 8.074M |
| Globus Medical, Inc. | 9.689B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 43.10M |
| Revenue (Quarterly) | 212.82M |
| Total Expenses (Quarterly) | 169.72M |
| EPS Diluted (Quarterly) | 0.5167 |
| Gross Profit Margin (Quarterly) | 86.44% |
| Profit Margin (Quarterly) | 20.25% |
| Earnings Yield | 1.37% |
| Operating Earnings Yield | 1.27% |
| Normalized Earnings Yield | 1.402 |